BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33022479
Number of visits today
7033
Number of downloads
16211927
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Conway R, Nikiphorou E. Treating interstitial lung disease in rheumatoid arthritis - the embers of hope. Rheumatology (Oxford) 2020;59:3589-90. [PMID: 33068432 DOI: 10.1093/rheumatology/keaa516] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Nasonov EL, Ananyeva LP, Avdeev SN. Interstitial lung disease in rheumatoid arthritis: A multidisciplinary problem in rheumatology and pulmonology. Naučno-praktičeskaâ revmatologiâ 2022;60:517-534. [DOI: 10.47360/1995-4484-2022-1] [Reference Citation Analysis]
2 Gialouri CG, Fragoulis GE. Is there room for better screening for lung cancer in rheumatoid arthritis? RMD Open 2022;8. [PMID: 36597974 DOI: 10.1136/rmdopen-2022-002774] [Reference Citation Analysis]
3 Kelly C, Emery P, Dieudé P. Current issues in rheumatoid arthritis-associated interstitial lung disease. The Lancet Rheumatology 2021;3:e798-e807. [DOI: 10.1016/s2665-9913(21)00250-2] [Cited by in Crossref: 6] [Article Influence: 3.0] [Reference Citation Analysis]
4 Cronin O, McKnight O, Keir L, Ralston SH, Hirani N, Harris H. A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease. Rheumatol Int 2021;41:921-8. [PMID: 33721094 DOI: 10.1007/s00296-021-04835-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345